Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tetanus | 1 | 2019 | 61 | 0.74 | Why? |
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2019 | 91 | 0.71 | Why? |
| Local Government | 1 | 2021 | 301 | 0.68 | Why? |
| Ventricular Fibrillation | 1 | 2018 | 126 | 0.65 | Why? |
| Mandatory Programs | 1 | 2021 | 291 | 0.63 | Why? |
| State Government | 1 | 2021 | 416 | 0.62 | Why? |
| Federal Government | 1 | 2021 | 562 | 0.55 | Why? |
| Vomiting | 1 | 2018 | 722 | 0.49 | Why? |
| Vaccination Refusal | 1 | 2019 | 831 | 0.41 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 1645 | 0.30 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.29 | Why? |
| Fungemia | 1 | 2004 | 86 | 0.27 | Why? |
| Amphotericin B | 1 | 2004 | 256 | 0.25 | Why? |
| Oregon | 2 | 2019 | 224 | 0.23 | Why? |
| Triazoles | 1 | 2004 | 440 | 0.21 | Why? |
| Gadolinium | 1 | 2021 | 318 | 0.20 | Why? |
| Endocarditis | 1 | 2004 | 368 | 0.19 | Why? |
| Masks | 1 | 2021 | 8528 | 0.18 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2004 | 676 | 0.17 | Why? |
| Pyrimidines | 1 | 2004 | 1557 | 0.16 | Why? |
| Transitional Care | 1 | 2018 | 135 | 0.16 | Why? |
| Troponin | 1 | 2021 | 1058 | 0.14 | Why? |
| Communicable Diseases | 2 | 2020 | 2148 | 0.13 | Why? |
| Antimicrobial Stewardship | 1 | 2019 | 931 | 0.11 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.10 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.09 | Why? |
| Survivors | 1 | 2020 | 2619 | 0.09 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.09 | Why? |
| Hospitals, Pediatric | 1 | 2018 | 1792 | 0.08 | Why? |
| Anti-Bacterial Agents | 2 | 2019 | 10083 | 0.08 | Why? |
| Bacterial Infections | 1 | 2019 | 2229 | 0.07 | Why? |
| Fusarium | 1 | 2004 | 44 | 0.07 | Why? |
| Magnetic Resonance Imaging | 1 | 2021 | 6551 | 0.07 | Why? |
| Voriconazole | 1 | 2004 | 206 | 0.06 | Why? |
| United States | 5 | 2021 | 46150 | 0.06 | Why? |
| Liposomes | 1 | 2004 | 334 | 0.06 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Ambulatory Care | 1 | 2018 | 4947 | 0.05 | Why? |
| Child Care | 1 | 2021 | 209 | 0.05 | Why? |
| Humans | 15 | 2021 | 930598 | 0.05 | Why? |
| Infusions, Parenteral | 1 | 2018 | 41 | 0.05 | Why? |
| Opportunistic Infections | 1 | 2004 | 602 | 0.04 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.04 | Why? |
| Epidemiologists | 1 | 2017 | 75 | 0.04 | Why? |
| Leadership | 2 | 2021 | 2241 | 0.04 | Why? |
| Child | 3 | 2021 | 70012 | 0.04 | Why? |
| Cost Savings | 1 | 2018 | 296 | 0.04 | Why? |
| Reimbursement Mechanisms | 1 | 2018 | 243 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 1573 | 0.03 | Why? |
| Antifungal Agents | 1 | 2004 | 1828 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Health Services Research | 1 | 2019 | 756 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Drug Therapy, Combination | 1 | 2004 | 7268 | 0.03 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.03 | Why? |
| Mothers | 1 | 2021 | 1624 | 0.03 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.03 | Why? |
| Interprofessional Relations | 1 | 2017 | 1013 | 0.03 | Why? |
| Drug Resistance, Bacterial | 1 | 2019 | 1414 | 0.02 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.02 | Why? |
| Public Health Practice | 1 | 2017 | 945 | 0.02 | Why? |
| Male | 2 | 2021 | 367725 | 0.02 | Why? |
| Public Health Administration | 1 | 2017 | 846 | 0.02 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Infection Control | 1 | 2017 | 23131 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2004 | 5150 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Resource Allocation | 1 | 2017 | 1771 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2004 | 17020 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Female | 3 | 2021 | 380317 | 0.02 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2021 | 5164 | 0.02 | Why? |
| Nursing Homes | 1 | 2020 | 4155 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2020 | 10998 | 0.01 | Why? |
| Infant | 1 | 2004 | 30274 | 0.01 | Why? |
| Risk Assessment | 1 | 2004 | 25439 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.01 | Why? |
| Treatment Outcome | 1 | 2004 | 51732 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Guzman-Cottrill's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(95)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(108)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_